Pursuant of regulation 30 of read with schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shelter Pharma has informed that the company is launching the new healthcare product on May 11, 2026. The newly launched product is a Folic Acid Tablet (Vitamin B-9 Supplement) developed as part of the Company’s continuous efforts towards expanding its healthcare and nutraceutical product portfolio. The launch of this product is expected to strengthen the Company’s market presence, enhance business growth opportunities, and support the Company’s long-term expansion strategy in the healthcare segment. The Company remains committed to introducing quality healthcare products and creating sustainable value for its stakeholders.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1806.45 |
| Dr. Reddys Lab | 1279.25 |
| Cipla | 1381.50 |
| Zydus Lifesciences | 1087.75 |
| Lupin | 2273.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: